News & Events

Research highlights

May 19, 2020

Researchers urge clinical trial of blood pressure drug to prevent lethal complication of COVID-19

Johns Hopkins researchers report they have identified a drug treatment that could—if given early enough—potentially reduce the risk of death from the most serious complication of COVID-19, also known as SARS-CoV-2 infection.

Read on.

May 18, 2020

Johns Hopkins researchers to use machine learning to predict heart damage in COVID-19 victims

Johns Hopkins researchers recently received a $195,000 Rapid Response Research grant from the National Science Foundation to, using machine learning, identify which COVID-19 patients are at risk of adverse cardiac events such as heart failure, sustained abnormal heartbeats, heart attacks, cardiogenic shock and death.

Read on.

DNA Helix

April 17, 2020

Gene variant in noncoding DNA linked to heart failure

When scientists scour the genome for disease-causing culprits, they wouldn’t ordinarily look in so-called noncoding regions, areas of repetitive DNA that do not code for proteins. Yet, that’s exactly where Johns Hopkins scientists found genomic variations in a new study of people with heart failure.

Read on.

Researchers create nanoparticle with ‘look and feel’ of red blood cells to soak up toxins

Johns Hopkins biomedical engineer Jordan Green and his colleagues have developed a nanoparticle that has the shape and “skin” of red blood cells. The red blood cell mimics can be injected into the bloodstream and circulate within vessels for long periods to absorb toxic substances.

Read on.


March 27, 2020

Hopkins BME Assists in COVID-19 Research Response

Johns Hopkins University has quickly mobilized to create a comprehensive response integrating dozens of fields of expertise to find solutions amidst the COVID-19 pandemic.

Read on.

March 6, 2020

Scientists develop free computer program to map blood flow ‘landscape’ in tumors

Johns Hopkins researchers have created a computer program for scientists at no charge that lets users readily quantify the structural and functional changes in the blood flow networks feeding tumors.

Read on.

Heart tissues within one of the launch-ready chambers.

March 4, 2020

Little tissue, big mission: Beating heart tissues to ride aboard the ISS

Launching no earlier than March 6, Johns Hopkins University will send heart muscle tissues, contained in a specially-designed tissue chip the size of a small cellphone, up to the microgravity environment of the International Space Station for one month of observation.

Read on.

February 26, 2020

Nanosize device ‘uncloaks’ cancer cells in mice and reveals them to the immune system

Scientists at Johns Hopkins report they have designed and successfully tested an experimental, super small package able to deliver molecular signals that tag implanted human cancer cells in mice and make them visible for destruction by the animals’ immune systems. The new method was developed, say the researchers, to deliver an immune system “uncloaking” device directly to cancer cells.

Read on.

February 25, 2020

CRISPR gene cuts may offer new way to chart human genome

In search of new ways to sequence human genomes and read critical alterations in DNA, researchers at Johns Hopkins Medicine say they have successfully used the gene cutting tool CRISPR to make cuts in DNA around lengthy tumor genes, which can be used to collect sequence information.

Read on.

The image shows green and blue blobs from under a microscope.

December 9, 2019

Little Size Holds Big Impact: Johns Hopkins Scientists Develop Nanocontainer to Ship Titan-Size Gene Therapies and Drugs Into Cells

Scientists at Johns Hopkins Medicine report they have created a tiny, nanosize container that can slip inside cells and deliver protein-based medicines and gene therapies of any size — even hefty ones attached to the gene-editing tool called CRISPR.

Read on.